Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway.
Learn More >
Hello Monica
We are not addressing "de-prescribing" we are addressing the description of mineral oil products in CCDD in this paper.
Please let us know if this answers your query.
The CCDD Team has been looking at how to describe the TMs (therapeutic moities) and NTPs (non-proprietary therapeutic products) for products containing mineral oil as an active ingredient substance. The attached document summaries the information and the rationale for the choice of the two concepts that will be used in the CCDD:
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Print
Email
CCDD: Describing products containing mineral oil
Twitter